Borosil Scientific Limited — Updates, 13-02-2026: General Updates
13-02-2026 | 03:02 pm
13-02-2026 | 03:02 pm
Borosil Scientific released its Q3 and 9MFY26 investor presentation. Consolidated EBITDA for 9MFY26 declined due to lower sales in Goel Scientific. The company targets 12-14% revenue CAGR and improved EBITDA margins, emphasizing 'Make in India' and exports.
No comments yet. Be the first to comment!
